Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 366-372

  Vargova K ^a   Toth Zsamboki, E ^a,b   Beres, B J ^a   Bencze, J ^a,b   Kerecsen, G ^a,b   Gulacsi Bardos, P ^a   Kiss, R G ^a,b   Preda, I ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Health Service Center   (Hungary)

Author keywords

Circulating endothelial cell count; Ischemic heart disease; Percutaneous coronary intervention; Soluble intercellular adhesion molecule 1; STEMI; von Willebrand factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE;

AGED; ANGINA PECTORIS; ANGIOPLASTY; CELL COUNT; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; VON WILLEBRAND FACTOR;

EID: 43949086866     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.005     Document Type: Article

References (20)

1. Van de Werf F., Ardisso D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force. Eur Heart J 24 (2003) 28-66
2. Andersen H.R., Nielsen T.T., Rasmusen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Eng J Med 349 (2003) 733-742
3. Mickelson J.K., Lakkis N.M., Villarreal-Levy G., Hughes B.J., and Smith C.W. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?. J Am Coll Cardiol 28 (1996) 345-353
4. Serrano C.V., Ramires J.A.F., Venturinelli M., et al. Coronary angioplasty results in leukocytes and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 29 (1997) 1276-1283
5. Azar R.R., McKay R.G., Kiernan F.J., et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80 11 (1997) 1476-1478
6. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 (2005) 179-190
7. Boos C.J., Lip G.Y., and Blann A.D. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 48 8 (2006) 1538-1547
8. Mutin M., Canavy I., Blann A., et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93 (1999) 2951-2958
9. Lee K.W., Lip G.Y., Tayebjee M., Foster W., and Blann A.D. Circulating endothelial cells, von Willebrand factor. IL-6 and prognosis in patients with acute coronary syndromes. Blood 105 (2005) 526-532
10. Armstrong E.J., Morrow D.A., and Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes. Part II. Acute-phase reactants and biomarkers of endothelial cell activation. Circulation 113 7 (2006) 152-155
11. O'Malley T., Ludlam C.A., Riemermsa R.A., and Fox K.A. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. Eur Heart J 22 14 (2001) 1226-1234
12. Short P.E., Williams C.E., Picken A.M., and Hill F.G. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci 39 (1982) 351-355
13. Silber S., Albertsson P., Aviles F., et al. Task force for percutaneous coronary intervention of the European Society of Cardiology. Guidelines for percutaneous coronary intervention. Eur Heart J 26 8 (2005) 804-848
14. Kloner R.A., and Rezkalla S.H. Cardiac protection during acute myocardial infarction: where do we stand in 2004?. JACC 44 4 (2004) 276-286
15. Szabó C. Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Pharmacol Res 52 (2005) 34-43
16. Ray K.K., Morrow D.A., Gibson C.M., et al. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: an ENTIRE-TIMI 23 substudy. Eur Heart J 26 5 (2005) 440-446
17. Soskin P., Mossard J.M., Arbogast R., et al. Variation in von Willebrand factor according to the treatment of acute myocardial infarction: physiopathological and clinical implications. Eur Heart J 15 4 (1994) 479-482
18. Sakai H., Goto S., Kim J.Y., et al. Plasma concentration of von Willebrand factor in acute myocardial infarction. Thromb Haemost 84 2 (2000) 204-209
19. Kamijikkoku S., Murohara T., Tayama S., et al. Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: a marker of vascular inflammation and a risk of early restenosis?. Am Heart J 136 2 (1998) 231-236
20. Haim M., Tanne D., Boyko V., et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the bezafibrate infarction prevention (BIP) study. J Am Coll Cardiol 39 7 (2002) 1133-1138